Company attributes
B2X
0
Legal Name
Hemispherx Biopharma, Inc.
Number of Employees (Ranges)
11 – 500
CIK Number
Place of Incorporation
IRS Number
520,845,822
Founded Date
1998
0Stock Symbol
HEB
Exchange
Country
Headquarters
Other attributes
Company Operating Status
Active
SIC Code
2,836
Wikidata ID
Hemispherx Biopharma Inc. was founded in 1990.The company has created an immunomodulatory double stranded RNA drug called Ampligen. The company developed Ampligen for use as a treatment for chronic fatigue syndrome.
In June, 2018, Hemispherx announced that Ampligen had shown effectiveness in activating the TLR3 without triggering T-cell regulatory activities.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.
